Download PDF

Diabetologia

, Volume 35, Issue 3, pp 272–276 | Cite as

Islet amyloid polypeptide immunoreactivity in the human fetal pancreas

  • P. A. In't Veld
  • F. Zhang
  • O. D. Madsen
  • G. Klöppel
Originals
Received:
Revised:

Summary

Islet amyloid polypeptide is known to localize to the adult human Beta cell. We analysed the immunoreactivity for islet amyloid polypeptide in a series of 29 human fetal pancreata (9–24 weeks of gestation) with respect to age dependency and cellular localization using an antibody raised against synthetic rat islet amyloid polypeptide 12–37. Cells immunoreactive for islet amyloid polypeptide were demonstrated in low numbers from week 13 onwards while insulin positivity was already present at 9 weeks of gestation. In the age group 13–16 gestational weeks, cells positive for insulin were 20-fold more frequent than cells positive for islet amyloid polypeptide. This difference gradually disappeared with age, reaching parity in the adult gland. Double immunostaining demonstrated that all islet amyloid polypeptide immunoreactivity co-localized with insulin. Co-expression of insulin and islet amyloid polypeptide was more frequent in Beta-cell clusters (≥10 cells) than in single Beta cells; islet amyloid polypeptide positivity was present in 58±9% (mean±SEM; n=4) of fetal, 88±9 % (n=3) of neonatal and 100% (n=3) of adult clustered Beta cells, and only 8–18 % of the single Beta cells. The results suggest that the developing fetal Beta cells, dependent on age and localization, differ in their capacity to express detectable amounts of immunoreactive islet amyloid polypeptide. Beta-cell maturation might therefore be associated with islet amyloid polypeptide expression.

Key words

Islet amyloid polypeptide fetal pancreas immunocytochemistry distribution age dependence 
Download to read the full article text

References

  1. 1.
    Westermark P, Wernstedt C, Wilander E, Sletten K (1986) A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140: 827–831PubMedGoogle Scholar
  2. 2.
    Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KB (1987) Purification and characterization of a peptide from amyloid-rich pancreas of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628–8632PubMedGoogle Scholar
  3. 3.
    Westermark P, Wilander E, Westermark GT, Johnson KH (1987) Islet amyloid polypeptide-like immunoreactivity in the islet B cells of Type 2 (non-insulin-dependent) diabetic and nondiabetic individuals. Diabetologia 30: 887–892PubMedGoogle Scholar
  4. 4.
    Clark A, Saad MF, Nezzer T et al. (1990) Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians. Diabetologia 33: 285–289PubMedGoogle Scholar
  5. 5.
    Porte D, Kahn SE (1989) Hyperproinsulinemia and amyloid in NIDDM: clues to etiology of islet β-cell dysfunction? Diabetes 38: 1333–1336PubMedGoogle Scholar
  6. 6.
    Lukinius A, Wilander E, Westermark GT, Engström U, Westermark P (1989) Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islet. Diabetologia 32: 240–244CrossRefPubMedGoogle Scholar
  7. 7.
    Johnson KH, O'Brien TD, Hayden DW et al. (1988) Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic Beta cells by means of peroxidase-antiperioxidase (PAP) and protein A-gold technique. Am J Pathol 130: 1–8PubMedGoogle Scholar
  8. 8.
    Madsen OD, Nielsen JH, Petersen JS, Kofod H, Dyrberg T (1990) Expression of islet amyloid polypeptide and insulin in the pancreatic islet cells. In: Shafrir E (ed) Frontiers in diabetes research. Lessons from animal diabetes III, Smith-Gordon, London, pp 512–515Google Scholar
  9. 9.
    Storch MJ, Petersen KG, Licht T, Kerp L (1985) Recognition of human insulin and proinsulin by monoclonal antibodies. Diabetes 34: 808–811PubMedGoogle Scholar
  10. 10.
    Rindi G, Terenghi G, Westermark G et al. (1991) Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice. Am J Pathol 138: 1321–1334PubMedGoogle Scholar
  11. 11.
    Clark A, Grant AM (1983) Quantitative morphology of endocrine cells in human fetal pancreas. Diabetologia 25: 31–35CrossRefPubMedGoogle Scholar
  12. 12.
    Stefan Y, Grasso S, Perrelet A, Orci L (1983) A quantitative immunofluorescent study of the endocrine cell populations in the developing human pancreas. Diabetes 32: 293–301PubMedGoogle Scholar
  13. 13.
    Madsen OD, Nielsen JH, Michelsen B et al. (1991) Islet amyloid polypeptide and insulin expression are controlled differently in primary and transformed islet cells. Molecular Endocrinology 5: 143–148PubMedGoogle Scholar
  14. 14.
    Nishi M, Sanke T, Nagamatsu S, Bell GI, Steiner DF (1990) Islet amyloid polypeptide, a new β cell secretory product related to islet amyloid deposits. J Biol Chem 265: 4173–4176PubMedGoogle Scholar
  15. 15.
    Pictet R, Rutter WJ (1972) Development of the embryonic endocrine pancreas. In: Steiner DF, Freinkel N (eds) Handbook of physiology, Vol. 1. The American Physiological Society, Bethesda, pp 25–66Google Scholar
  16. 16.
    Le Douarain NM (1988) On the origin of pancreatic endocrine cells. Cell 53: 169–171CrossRefPubMedGoogle Scholar
  17. 17.
    Dubois PM (1989) Ontogeny of the endocrine pancreas. Hormone Res 32: 53–60PubMedGoogle Scholar
  18. 18.
    Rahier J, Wallon J, Henquin JC (1981) Cell populations in the endocrine pancreas of human neonates and infants. Diabetologia 20: 540–546CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • P. A. In't Veld
    • 1
  • F. Zhang
    • 1
  • O. D. Madsen
    • 2
  • G. Klöppel
    • 1
  1. 1.Department of PathologyFree University of Brussels (Jettes)BrusselsBelgium
  2. 2.Hagedorn Research LaboratoryGentofteDenmark

Personalised recommendations